Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director Matthew Shair sold shares of Nuvalent, Inc. under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock on May 6, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
- A total of 37,500 shares were sold in multiple transactions at weighted average prices of $69.27 and $70.27.
- Following the transactions, Shair directly owns 1,462,198 shares of Class A Common Stock.
- Additionally, 236,522 shares are held indirectly through the Matthew D. Shair 2021 Irrevocable Family Trust, over which Shair has voting and dispositive power.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion on the company's performance or future prospects.
Industry Context
Sales by insiders are a common occurrence and are often related to personal financial planning rather than a reflection of the company's prospects.
Stakeholder Impact
- The share sales by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.
Key Dates
| Date | Description |
|---|---|
| 12/21/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/06/2024 | Date of share sale transactions |
| 05/08/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.